FL S1676

Caps cost-sharing for insulin, noninsulin, and glucagon drugs at $35 per 30-day supply and diabetes/diabetic ketoacidosis devices at $100 per 30-day supply across health insurance policies and health maintenance contracts, effective January 1, 2026.

Authorizes pharmacists to immediately prescribe and dispense up to a 30-day supply of insulin, glucagon drugs, diabetes devices, and diabetic ketoacidosis devices to patients with less than a 7-day supply who face significant physical harm, limited to once per 12-month period.

Requires the Department of Health to create and maintain a website that collects patient information, identifies reduced-cost medications available through federally qualified health centers or covered entities, and facilitates referrals for uninsured or cost-burdened patients.

Federally qualified health centers or covered entities receiving a referral through the Department of Health website must make a good faith effort to schedule an appointment within 30 days of receiving patient information.

Requires dispensers to report all insulin drugs, glucagon drugs, diabetes devices, and diabetic ketoacidosis devices to the state's electronic prescription drug monitoring program, in the same manner as controlled substances.